Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)
298.80
-31.20 (-9.45%)
At close: May 11, 2026
HKG:2526 Revenue
In the year 2025, Hangzhou Diagens Biotechnology had annual revenue of 164.42M CNY with 133.72% growth. Hangzhou Diagens Biotechnology had revenue of 52.81M in the quarter ending December 31, 2025.
Revenue
164.42M CNY
Revenue Growth
+133.72%
P/S Ratio
160.30
Revenue / Employee
990.51K CNY
Employees
166
Market Cap
29.33B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 164.42M | 94.07M | 133.72% |
| Dec 31, 2024 | 70.35M | 17.51M | 33.13% |
| Dec 31, 2023 | 52.84M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition